Early research (Phase 1)Study completedNCT03086642What this trial is testingStudy of Talimogene Laherparepvec (T-VEC) in Pancreatic CancerWho this might be right forPancreatic Cancer Karie D. Runcie, MD 10
Early research (Phase 1)Study completedNCT04148937What this trial is testingThe CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 52
Early research (Phase 1)Active Not RecruitingNCT07457541What this trial is testingMolecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPIWho this might be right forLung Cancer (Locally Advanced or Metastatic)Pancreas Cancer, MetastaticBreast Cancer (Locally Advanced or Metastatic)+1 more Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Large-scale testing (Phase 3)Study completedNCT00024427What this trial is testingTriacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganPancreatic Cancer Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Ended earlyNCT00429858What this trial is testingGemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Andrew Ko 21
Early research (Phase 1)WithdrawnNCT06206876What this trial is testingFL118 for Treating Patients With Advanced Pancreatic Ductal AdenocarcinomaWho this might be right forAdvanced Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma+5 more Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT01204476What this trial is testingCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT01601808What this trial is testingClinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic CarcinomaWho this might be right forPancreatic Cancer University of Liverpool 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648What this trial is testingPersonalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.Who this might be right forPancreatic Cancer MetastaticPancreatic Cancer Non-resectable Zhejiang University 30
Large-scale testing (Phase 3)Study completedNCT00561990What this trial is testingNimotuzumab in Adults With Pancreatic CancerWho this might be right forPancreatic Cancer, Advanced or Metastatic Oncoscience AG 188
Early research (Phase 1)Looking for participantsNCT06500052What this trial is testingBL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsWho this might be right forEsophageal CancerGastric CancerPancreatic Cancer+2 more Sichuan Baili Pharmaceutical Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT01746979What this trial is testingClinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic AdenocarcinomaWho this might be right forMetastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma ImmunoGenesis 693
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Looking for participantsNCT06040541What this trial is testingStudy of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsWho this might be right forNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Revolution Medicines, Inc. 604
Very early researchEnded earlyNCT00414570What this trial is testingAn Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside AnalogsWho this might be right forPancreatic Cancer AHS Cancer Control Alberta 11
Not applicableUnknownNCT04667403What this trial is testingTelemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic CancerWho this might be right forAdenocarcinomaPancreatic Cancer MetastaticPain Institut Cancerologie de l'Ouest 50
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00871169What this trial is testingCombination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer New Mexico Cancer Research Alliance 61
Post-approval studies (Phase 4)UnknownNCT03401827What this trial is testingThe Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerWho this might be right forPancreatic AdenocarcinomaChemotherapy Effect Seoul National University Hospital 40
Early research (Phase 1)UnknownNCT00090727What this trial is testingChemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forSolid MalignanciesNon-Hodgkin's Lymphoma Novacea 45